<DOC>
	<DOCNO>NCT02726659</DOCNO>
	<brief_summary>The investigator conduct 6-week , randomize , double-blind , placebo-controlled trial celecoxib add-on treatment mood stabilizer among woman bipolar I II postpartum depression . Women take mood stabilizer treatment bipolar disorder postpartum treatment receive either placebo celecoxib add-on treatment . Patients monitor regularly assess psychiatric symptom side effect . The investigator aim evaluate potential antidepressant effect celecoxib bipolar postpartum depression .</brief_summary>
	<brief_title>Adjunctive Use Celecoxib Treatment Bipolar Postpartum Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depression , Postpartum</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>woman age 1845 within 3 month deliver healthy , term ( 37 40 week ) singleton diagnosis bipolar postpartum depression depress peripartum onset 17item Hamilton Rating Scale Depression score &gt; 18 fail respond adequate trial mood stabilizer currently psychotropic drug except mood stabilizer ( lithium , lamotrigine quetiapine ) able communicate ( write oral ) English capable give consent current major depressive episode 6 month duration current comorbid psychiatric disorder history alcohol substance abuse within 12 month screen concurrent psychotherapy high risk suicide ( actively suicidal score = 3 item # 3 HAMD ) current hepatic , renal , cardiac disease , chronic pain , coagulation disorder , esophageal gastro duodenal ulceration within previous 30 day know immediatetype hypersensitivity COX2 inhibitor , sulfonamide , ibuprofen , diclofenac breastfeeding mother</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>